Director, Directorate Health,
DG Research and Innovation, European Commission
Dr Ruxandra Draghia-Akli is Director of the Health Directorate at the Research DG of the
Previously, Ruxandra Draghia-Akli served as Vice President of Research at Inovio
Pharmaceuticals and VGX Animal Health.
Dr. Draghia's research activities have focused on plasmid design, gene expression and
tissue-specific promoters/enhancers and sequences for the efficient expression of either
secreted or intracellular proteins for gene therapy and vaccination.
She is recognised as
a global leader in the field of nucleic acid delivery for therapeutic and vaccination
applications. She is an inventor on more than a hundred patents and patent applications.
Throughout her career, Dr. Draghia has published numerous scientific papers and
reviews in the areas of electroporation, plasmid components, growth and development,
immune stimulation, vaccination, health, and well-being. She served as ad-hoc reviewer
for granting agencies, annual meetings for gene therapy and endocrinology societies,
and scientific journals in Europe and the USA.
Dr. Draghia received an M.D. from Carol Davilla Medical School and a Ph.D. in human
genetics from the Romanian Academy of Medical Sciences.
Dr. Draghia also completed
a doctoral fellowship at the University of Rene Descartes in Paris and a post-doctoral
training at Baylor College of Medicine (BCM), Houston, Texas, USA, and served as
faculty at BCM.